Justices Warned That Biogen's Loss Will End Drug Patents
The top lobbying groups for the pharmaceutical and biotech industry have told the U.S. Supreme Court that a loss one of their members suffered at the Federal Circuit in a fight...To view the full article, register now.
Already a subscriber? Click here to view full article